Top

Published in:

01-03-2019 | Original Article

Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients—a Tertiary Experience

Authors: Ravindra Pramod Deshpande, Chandrasekhar Y. B. V. K., Manas Panigrahi, Phanithi Prakash Babu

Published in: Indian Journal of Surgical Oncology | Issue 1/2019

Abstract

Astrocytoma constitutes the most noted malignancies of the central nervous system with worse clinical outcomes in grade IV astrocytoma or glioblastoma multiforme. Owing to poor clinical outcomes with existing therapeutic regime, there is a need to revisit the initial course of treatment. Statistical information of clinicopathological parameters could be used to understand the spread of disease and, in turn, to formulate updated treatment management. In the present study, we have seen anatomic distribution of astrocytoma subtypes in a group of 479 patients and correlated it with survival outcomes. Anatomic location was confirmed by MRI (magnetic resonance imaging) images. A registry of patients was maintained with clinicopathological details as tumor type, location, age/sex, and survival after surgery. We have observed overall survival particulars in patients diagnosed with astrocytoma. Our findings highlight that in total cases, tumor location was anatomically dominated by frontal and temporal lobes. Survival analysis in high-grade (grade III, p = 0.03; grade IV, p = 0.01) astrocytic tumors confirms poor outcomes with temporal, parietal, and occipital location as compared to frontal lobe. Overall survival study demonstrates glioblastoma multiforme (GBM) was associated with worse prognosis as compared to astrocytoma subtypes (p < 0.0001). In high-grade astrocytomas, anaplastic astrocytoma was found with 34 months of median survival age while 14 months in the case of patients with glioblastoma multiforme. In conclusion, we report dismal prognosis in parietal, temporal, and occipital lobes in grade II, grade III, and grade IV astrocytoma patients. Among astrocytoma subtypes, patients with glioblastoma multiforme were associated with worse survival outcomes. We uniquely feature the survival of astrocytoma patients for the first time and observe GBM patients have slightly longer survival.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. https://doi.org/10.1007/s00401-007-0243-4 CrossRefPubMedPubMedCentral

Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology 14(Suppl 5):v1–v49. https://doi.org/10.1093/neuonc/nos218

Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A, Tourdias T, Kantor G, Maire JP, Vital A, Loiseau H, and the Gironde TSNC Registry Group, Champeaux K, Dhauteribes M, Eimer S, Gimbert E, Liguoro D, Monteil P, Penchet G, San-Galli F, Vignes J (2011) Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro-Oncology 13(12):1370–1378. https://doi.org/10.1093/neuonc/nor120 CrossRefPubMedPubMedCentral

van den Bent MJ, Bromberg JE (2015) Neuro-oncology: the many challenges of treating elderly glioblastoma patients. Nat Rev Neurol 11(7):374–375. https://doi.org/10.1038/nrneurol.2015.82 CrossRefPubMed

Walid MS (2008) Prognostic factors for long-term survival after glioblastoma. Perm J 12(4):45–48CrossRefPubMedPubMedCentral

Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro-Oncology 6(3):227–235CrossRefPubMedPubMedCentral

Deshpande RP, Babu D, Panigrahi M, Chandra Sekhar YB, Prakash Babu P (2016) Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India. J Neuro-Oncol 129(2):383–387. https://doi.org/10.1007/s11060-016-2183-0 CrossRef

Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S et al (2006) Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 65(9):846–854CrossRefPubMed

Kraus JA, Glesmann N, Beck M, Krex D, Klockgether T, Schackert G, Schlegel U (2000) Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. J Neuro-Oncol 48(2):89–94CrossRef

10.

Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncology 4(4):278–299CrossRefPubMedPubMedCentral

11.

Peters O, Gnekow AK, Rating D, Wolff JE (2004) Impact of location on outcome in children with low-grade oligodendroglioma. Pediatr Blood Cancer 43(3):250–256. https://doi.org/10.1002/pbc.20111 CrossRefPubMed

12.

Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y (1994) Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neuro-Oncol 21(2):177–185CrossRef

13.

Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, Weinstein AS, Nelson DF (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26(2):239–244CrossRefPubMed

14.

Duffau H, Capelle L (2004) Preferential brain locations of low-grade gliomas. Cancer 100(12):2622–2626. https://doi.org/10.1002/cncr.20297 CrossRefPubMed

15.

Larjavaara S, Mantyla R, Salminen T, Haapasalo H, Raitanen J, Jaaskelainen J et al (2007) Incidence of gliomas by anatomic location. Neuro-Oncology 9(3):319–325. https://doi.org/10.1215/15228517-2007-016 CrossRefPubMedPubMedCentral

16.

Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, Criniere E, Capelle L, Duffau H, Cornu P, Broet P, Kujas M, Mokhtari K, Carpentier A, Sanson M, Hoang-Xuan K, Thillet J, Delattre JY (2004) Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology 63(12):2360–2362CrossRefPubMed

17.

Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A (2002) Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161(1):313–319. https://doi.org/10.1016/S0002-9440(10)64183-1 CrossRefPubMedPubMedCentral

18.

Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61(18):6713–6715PubMed

19.

Ali Kahn A, O'Brien DF, Kelly P, Phillips JP, Rawluk D, Bolger C, Pidgeon CN (2003) The anatomical distribution of cerebral gliomas in mobile phone users. Ir Med J 96(8):240–242PubMed

20.

Liu TT, Achrol AS, Mitchell LA, Du WA, Loya JJ, Rodriguez SA et al (2016) Computational identification of tumor anatomic location associated with survival in 2 large cohorts of human primary glioblastomas. AJNR Am J Neuroradiol 37(4):621–628. https://doi.org/10.3174/ajnr.A4631. CrossRefPubMedPubMedCentral

21.

Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62(4):753–764; discussion 264-6. https://doi.org/10.1227/01.neu.0000318159.21731.cf CrossRefPubMed

22.

Colen RR, Vangel M, Wang J, Gutman DA, Hwang SN, Wintermark M et al (2014) Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project. BMC Med Genet 7:30. https://doi.org/10.1186/1755-8794-7-30 CrossRef

23.

Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-Oncology 9(4):424–429. https://doi.org/10.1215/15228517-2007-023 CrossRefPubMedPubMedCentral

24.

Ostrom QT, Gittleman H, Kruchko C, Louis DN, Brat DJ, Gilbert MR, Petkov VI, Barnholtz-Sloan JS (2016) Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying). J Neuro-Oncol 130(1):31–42. https://doi.org/10.1007/s11060-016-2217-7 CrossRef

Title: Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients—a Tertiary Experience
Authors: Ravindra Pramod Deshpande
Chandrasekhar Y. B. V. K.
Manas Panigrahi
Phanithi Prakash Babu
Publication date: 01-03-2019
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 1/2019
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-018-0820-0

At a glance: The STEP trials

Springer Medicine

Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients—a Tertiary Experience

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Prognostic Utility of Cyclin D1 in Invasive Breast Carcinoma

Perioperative Mortality in Cancer Esophagus—a Case Control Study at a High-Volume Regional Cancer Center in South India

Endometrial Stromal Sarcoma: Case Series with Emphasis on Gross Features

Cytoreductive Surgery in Combination with HIPEC in the Treatment of Peritoneal Sarcomatosis

CR-Possum—Can It Be Used to Predict Morbidity? A Single-Centre Retrospective Study

Outcome of 150 Consecutive Blumgart’s Pancreaticojejunostomy After Pancreaticoduodenectomy